653 related articles for article (PubMed ID: 20702695)
1. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of mTOR signaling in fragile X syndrome.
Sharma A; Hoeffer CA; Takayasu Y; Miyawaki T; McBride SM; Klann E; Zukin RS
J Neurosci; 2010 Jan; 30(2):694-702. PubMed ID: 20071534
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.
Muddashetty RS; Kelić S; Gross C; Xu M; Bassell GJ
J Neurosci; 2007 May; 27(20):5338-48. PubMed ID: 17507556
[TBL] [Abstract][Full Text] [Related]
4. Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110β-selective inhibitor.
Gross C; Bassell GJ
Mol Med; 2012 May; 18(1):336-45. PubMed ID: 22207187
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.
Niere F; Wilkerson JR; Huber KM
J Neurosci; 2012 Apr; 32(17):5924-36. PubMed ID: 22539853
[TBL] [Abstract][Full Text] [Related]
6. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
Nakamoto M; Nalavadi V; Epstein MP; Narayanan U; Bassell GJ; Warren ST
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15537-42. PubMed ID: 17881561
[TBL] [Abstract][Full Text] [Related]
7. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis.
Auerbach BD; Bear MF
J Neurophysiol; 2010 Aug; 104(2):1047-51. PubMed ID: 20554840
[TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins.
Schmit TL; Dowell JA; Maes ME; Wilhelm M
J Neurochem; 2013 Dec; 127(6):772-81. PubMed ID: 24047560
[TBL] [Abstract][Full Text] [Related]
9. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
Nosyreva ED; Huber KM
J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
[TBL] [Abstract][Full Text] [Related]
11. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
Zhang L; Alger BE
J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.
Antar LN; Afroz R; Dictenberg JB; Carroll RC; Bassell GJ
J Neurosci; 2004 Mar; 24(11):2648-55. PubMed ID: 15028757
[TBL] [Abstract][Full Text] [Related]
13. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
14. Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model.
Gross C; Banerjee A; Tiwari D; Longo F; White AR; Allen AG; Schroeder-Carter LM; Krzeski JC; Elsayed NA; Puckett R; Klann E; Rivero RA; Gourley SL; Bassell GJ
Neuropsychopharmacology; 2019 Jan; 44(2):324-333. PubMed ID: 30061744
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
16. Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation.
Nalavadi VC; Muddashetty RS; Gross C; Bassell GJ
J Neurosci; 2012 Feb; 32(8):2582-7. PubMed ID: 22357842
[TBL] [Abstract][Full Text] [Related]
17. Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.
Kumari D; Bhattacharya A; Nadel J; Moulton K; Zeak NM; Glicksman A; Dobkin C; Brick DJ; Schwartz PH; Smith CB; Klann E; Usdin K
Hum Mutat; 2014 Dec; 35(12):1485-94. PubMed ID: 25224527
[TBL] [Abstract][Full Text] [Related]
18. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
[TBL] [Abstract][Full Text] [Related]
19. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Henderson C; Wijetunge L; Kinoshita MN; Shumway M; Hammond RS; Postma FR; Brynczka C; Rush R; Thomas A; Paylor R; Warren ST; Vanderklish PW; Kind PC; Carpenter RL; Bear MF; Healy AM
Sci Transl Med; 2012 Sep; 4(152):152ra128. PubMed ID: 22993295
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated NMDA-Receptor Signaling Inhibits Long-Term Depression in a Mouse Model of Fragile X Syndrome.
Toft AK; Lundbye CJ; Banke TG
J Neurosci; 2016 Sep; 36(38):9817-27. PubMed ID: 27656021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]